Clinical Performance of the VESTO® Vascular Stent for Treatment of Iliac Peripheral Obstructive Arterial Disease

Inclusion Criteria:

1. 18 years of age or older;

2. TASC-II aortoiliac lesion classification of modified class A, B, C, or D;

3. Rutherford classification score of 2 to 5;

4. Access site compatibility with the device delivery system;

5. Compliance with the device's instructions for use (IFU);

6. Patient availability for appropriate follow-up times for the duration of the study;

7. Patient informed about the nature of the study, agreeing to its provisions, andsigning the informed consent form.

Exclusion Criteria:

1. Known hypersensitivity to heparin, contrast media, or stent components;

2. Patient with blood dyscrasia;

3. Pregnant or breastfeeding women;

4. Patient currently participating in an investigational drug or device study;

5. Patient undergoing chemotherapy or radiation therapy;

6. Patient with a stent or graft located in the target limb;

7. Patient who underwent angioplasty or bypass surgery within 30 days prior toinclusion in this study;

8. Patient with a life expectancy of less than 12 months;

9. Inability to undergo dual antiplatelet therapy (DAPT)